Ecological Momentary Assessment (EMA)

BEHAVIORAL8 trials

Sponsors

Glenn-Milo Santos, Birgit Watzke, University Hospital, Bordeaux, Massachusetts General Hospital, Rutgers, The State University of New Jersey

Conditions

Cocaine Use DisorderDepressionRestless Legs SyndromeStrokeSuicidal IdeationSuicideSuicide Attempt

Phase 2

Treatment With Lorcaserin for Cocaine Use: The TLC Study

TerminatedNCT03192995

Glenn-Milo SantosCocaine Use Disorder

Start: 2018-01-01End: 2020-06-30Updated: 2023-08-14

Unknown Phase

Intersession Processes in Psychotherapeutic Treatments Using an Ecological Momentary Assessment Approach (ISA-Bell)

RecruitingNCT05553197

Birgit WatzkeDepression

Start: 2022-11-01End: 2026-05-31Target: 84Updated: 2025-06-25

Ecological Momentary Assessment in Patients With Restless Legs Syndrome

RecruitingNCT05695963

University Hospital, BordeauxRestless Legs Syndrome

Start: 2024-01-15End: 2027-01-31Target: 62Updated: 2025-11-20

Real-time Intervention for Suicide Risk Reduction

CompletedNCT05848089

Massachusetts General HospitalSuicidal Ideation, Suicide Attempt

Start: 2023-09-25End: 2025-02-19Updated: 2025-11-10

Addiction & Stroke

RecruitingNCT06187025

University Hospital, BordeauxStroke

Start: 2024-02-07End: 2027-08-07Target: 300Updated: 2025-07-20

Randomized Clinical Trial of Supplementing Brief Psychotherapy With a Mobile App

RecruitingNCT06555094

Rutgers, The State University of New JerseySuicidal Ideation, Suicide, Suicide Attempt

Start: 2024-05-14End: 2025-01-31Target: 50Updated: 2024-08-15

Post-Stroke Secondary Prevention With Digital Monitoring

RecruitingNCT06837311

University Hospital, BordeauxStroke

Start: 2025-03-25End: 2028-03-25Target: 388Updated: 2025-07-21

Functional Connectivity of the Interoceptive Network in RLS

RecruitingNCT07001891

University Hospital, BordeauxRestless Legs Syndrome

Start: 2025-09-16End: 2026-10-31Target: 30Updated: 2025-09-17

Related Papers

Pilot study of extended-release lorcaserin for cocaine use disorder among men who have sex with men: A double-blind, placebo-controlled randomized trial

PLoS ONE2021-07-1510 citations